News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

ZALTRAP™ Incyte (INCY) Gilead (GILD) Vitae Pharmaceuticals (VTAE) Biogen Idec (BIIB) Micromet (MITI) AERIE PHARMACEUTICALS RenenxBio (RGNX) Roche (RHHBY) Sanofi-Aventis (SAN) Advaxis (ADXS) Prosensa (RNA) Aimmune Therapeutics (AIMT) MODERNA Sangamo (SGMO) Herceptin Global Cell Therapeutics (GBT) CEMPRA (CEMP) GUARDIAN HEALTH Ziofpharm (ZIOP) Endometrial Cancer Dynavax (DVAX) Velcade (bortezomib) SYNTA (SNTA) Ridaforolimus Prolor Biotech (PBTH) Regeneron (REGN) Sanofi (SNY) Mirati Therapeutics (MRTX) KITE (KITE) INNOVIVA (INVA) NEKTAR (NKTR)) Anacor (ANAC) ISIS (ISIS) Human Genome Sciences (HGSI) Galena (GALE) Sequenom (SQNM) ARGOS (ARGS) Vertex (VRTX) VANDA (VNDA) Tysabri ADVENTRIX (ANX) Ionis (IONS) JUNO (JUNO) AstraZeneca (AZN) Elan (ELN) Intermune (ITMN) Spike Therapeutics (ONCE) Illumina (ILMN) TOKAI (TKAOI) Genentech Alnylam (ALNY) CRISPR Therapeutics (CRSP) ACADIA (ACAD) Rapamune REGULUS (RGLS) Agenus (AGEN) Sarepta (SRPT) GlaxoSmithKline (GSK) Human Longevity (HLI) BIOMARIN (BMRN) Onyx (ONXX) C4 Therapeutics Intercept (ICPT) Abbott Laboratories (ABT) Pluristem (PSTI) Multiple Myeloma Zerenex PORTOLA (PTLA) Dendreon (DNDN) Xoma (XOMA) CompuGen (CGEN) galapagos (GLPG) OSI (OSIP) AGOS (ARGS) Telaprevir Amgen (AMGN) Valeant Pharmaceuticals International (VRX) IDERA (IDRA) Sanofi (SNA) Bristol-Myers Squibb (BMY) Intrexon (XON) Inovio (INO) Auspex (ASPX) NOVOCURE (NVCR) Alder Biopharmaceuticals (ALDR) Roche (ROCHE) Cytokinetics (CYTK) PTC Therapeutics (PTCT) ABBVIE (ABBV) SERES THERAPEUTICS (MCRB) KERYX (KERX) Theravance Bio Pharma (TBPH) Ocular Therapeutix (OCUL) Theravance (THRX) Jazz Pharmaceuticals (JAZZ) Biocryst (BCRX) Array Pharmaceuticals (ARRY) Revlimid (lenolidamide) Ariad (ARIA) Seattle Genetics (SGEN) Anadys (ANDS) Exelixis (EXEL) Benlysta (belimumab) HALOZYME (HALO) Merck (MRK) Adaptimmune (ADAP) Editas (EDIT) NANTKWEST (NK) Bellicum (BLCM) SUNESIS PHARMACEUTICALS (SNSS) ImmunoGen (IMGN) Trastuzumab-DM1 ARCA (ABIO) Idenix (IDIX) Agenus (AGEN